Briumvi’s Phase 3 trial of an at-home injection has completed enrollment, testing an under-the-skin version against IV ...
In MS, mindfulness may increase the time spent asleep while in bed, but exercise appears to have inconsistent effects on ...
Bionxt has completed manufacturing of a batch of BNT23001, its under-the-tongue formulation of cladribine, for use in MS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results